The store will not work correctly when cookies are disabled.
4-acryloyl-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one
ID: ALA2287730
PubChem CID: 76316494
Max Phase: Preclinical
Molecular Formula: C20H22O3
Molecular Weight: 310.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CC(=O)C1=C(c2c(C)cc(C)cc2C)C(=O)OC12CCCC2
Standard InChI: InChI=1S/C20H22O3/c1-5-15(21)18-17(16-13(3)10-12(2)11-14(16)4)19(22)23-20(18)8-6-7-9-20/h5,10-11H,1,6-9H2,2-4H3
Standard InChI Key: VFKHLINECLXDDK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
27.5395 -11.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2932 -11.4695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2249 -10.6548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4288 -10.4680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0053 -11.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6228 -11.9648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6217 -12.7843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3297 -13.1933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0394 -12.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0366 -11.9612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3280 -11.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3255 -10.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9137 -13.1924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7477 -13.1913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7429 -11.5498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5135 -11.8175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5363 -10.4954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7549 -10.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1015 -10.2439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.7507 -12.5995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5340 -13.3846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5678 -12.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9853 -13.2918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
11 12 1 0
7 13 1 0
9 14 1 0
10 15 1 0
15 16 2 0
16 5 1 0
5 17 1 0
17 18 1 0
18 15 1 0
18 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
22 23 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 310.39 | Molecular Weight (Monoisotopic): 310.1569 | AlogP: 3.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.37 | Molecular Species: ┄ | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.54 | CX LogD: 5.54 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: 0.39 |
References
1. Zhao JH, Wang ZC, Ji MH, Cheng JL, Zhu GN, Yu CM.. (2012) Synthesis and bioactivity evaluation of novel spiromesifen derivatives., 68 (1): [PMID:21997953] [10.1002/ps.2248] |